Boston Children's Hospital formerly known as Children's Hospital Boston until 2012 is a nationally ranked, freestanding acute care children's hospital located in Boston, Massachusetts, adjacent both to its teaching affiliate, Harvard Medical School, and to Dana-Farber Cancer Institute.

During the past decade, Harvard Medical School / Boston Children's Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harvard Medical School / Boston Children's Hospital" #1 sponsor was "ACADIA Pharmaceuticals Inc." with 3 trials, followed by "Celgene" with 3 trials sponsored, "University of Pittsburgh" with 3 trials sponsored, "Marinus Pharmaceuticals" with 2 trials sponsored and "PTC Therapeutics" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harvard Medical School / Boston Children's Hospital" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Crohn's and Colitis Foundation" with 1 trials as a collaborator and "International Foundation for CDKL5 Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Harvard Medical School / Boston Children's Hospital" are "Crohn Disease" (3 trials), "Rett Syndrome" (3 trials), "Acute Liver Failure" (2 trials), "Duchenne Muscular Dystrophy" (2 trials) and "Hepatic Encephalopathy" (2 trials). Many other conditions were trialed in "Harvard Medical School / Boston Children's Hospital" in a lesser frequency.

Most popular intervention types in "Harvard Medical School / Boston Children's Hospital" are "Drug" (17 trials), "Other" (8 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ozanimod" (3 trials), "Ataluren" (2 trials), "Trofinetide" (2 trials) and "Artisan Aphakia Intraocular Lens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harvard Medical School / Boston Children's Hospital" are 18 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Harvard Medical School / Boston Children's Hospital". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 9 completed trials in Harvard Medical School / Boston Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Harvard Medical School / Boston Children's Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".